anonymous
Guest
anonymous
Guest
"Shares of Allergan rose as much as 3 percent in early trading Tuesday after Carl Icahn revealed a "large position" in the pharmaceutical company.
Famed activist investor Icahn expressed support for Allergan CEO Brent Saunders in a statement posted on Icahn's website.
"We were instrumental in bringing Brent on board as the new CEO of Forest Labs a few years ago and worked cooperatively and constructively with him to help increase value for all Forest shareholders," the statement said. "Less than a year later Forest was acquired by Actavis (which subsequently merged with Allergan) resulting in massive gains for Forest shareholders. While we at that time disposed of our position in Forest, we still have always maintained great respect for Brent."
Allergan did not immediately respond to CNBC's request for comment.
Allergan shares have lost 24.5 percent so far this year amid a failed merger agreement with rival Pfizer" Less
Famed activist investor Icahn expressed support for Allergan CEO Brent Saunders in a statement posted on Icahn's website.
"We were instrumental in bringing Brent on board as the new CEO of Forest Labs a few years ago and worked cooperatively and constructively with him to help increase value for all Forest shareholders," the statement said. "Less than a year later Forest was acquired by Actavis (which subsequently merged with Allergan) resulting in massive gains for Forest shareholders. While we at that time disposed of our position in Forest, we still have always maintained great respect for Brent."
Allergan did not immediately respond to CNBC's request for comment.
Allergan shares have lost 24.5 percent so far this year amid a failed merger agreement with rival Pfizer" Less